Literature DB >> 9708319

A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists.

M de Zwart1, R Link, J K von Frijtag Drabbe Künzel, G Cristalli, K A Jacobson, A Townsend-Nicholson, A P IJzerman.   

Abstract

Various adenosine analogues were tested at the adenosine A2B receptor. Agonist potencies were determined by measuring the cyclic AMP production in Chinese Hamster Ovary cells expressing human A2B receptors. 5'-N-Substituted carboxamidoadenosines were most potent. 5'-N-Ethylcarboxamidoadenosine (NECA) was most active with an EC50 value of 3.1 microM. Other ribose modified derivatives displayed low to negligible activity. Potency was reduced by substitution on the exocyclic amino function (N6) of the purine ring system. The most active N6-substituted derivative N6-methyl-NECA was 5 fold less potent than NECA. C8- and most C2-substituted analogues were virtually inactive. 1-Deaza-analogues had a reduced potency, 3- and 7-deazaanalogues were not active.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708319      PMCID: PMC3459057          DOI: 10.1080/07328319808004215

Source DB:  PubMed          Journal:  Nucleosides Nucleotides        ISSN: 0732-8311


  24 in total

1.  Characterization of the human brain putative A2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cells.

Authors:  S P Alexander; J Cooper; J Shine; S J Hill
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  The role of the 5'-hydroxyl group of adenosine in determining substrate specificity for adenosine deaminase.

Authors:  A Bloch; M J Robins; J R McCarthy
Journal:  J Med Chem       Date:  1967-09       Impact factor: 7.446

3.  Synthesis and biological activity of some new N6-substituted purine nucleosides.

Authors:  M H Fleysher; A Bloch; M T Hakala; C A Nichol
Journal:  J Med Chem       Date:  1969-11       Impact factor: 7.446

4.  Functional coupling of human adenosine receptors to a ligand-dependent reporter gene system.

Authors:  M J Castañón; W Spevak
Journal:  Biochem Biophys Res Commun       Date:  1994-01-28       Impact factor: 3.575

5.  Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.

Authors:  C Gallo-Rodriguez; X D Ji; N Melman; B D Siegman; L H Sanders; J Orlina; B Fischer; Q Pu; M E Olah; P J van Galen
Journal:  J Med Chem       Date:  1994-03-04       Impact factor: 7.446

6.  Molecular cloning and characterization of the human A3 adenosine receptor.

Authors:  C A Salvatore; M A Jacobson; H E Taylor; J Linden; R G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

7.  The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim.

Authors:  S M Michalek; R N Moore; J R McGhee; D L Rosenstreich; S E Mergenhagen
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

8.  Acting via A2 receptors, adenosine inhibits the production of tumor necrosis factor-alpha of endotoxin-stimulated human polymorphonuclear leukocytes.

Authors:  M Thiel; A Chouker
Journal:  J Lab Clin Med       Date:  1995-09

9.  Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts.

Authors:  L E Brackett; J W Daly
Journal:  Biochem Pharmacol       Date:  1994-03-02       Impact factor: 5.858

10.  2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.

Authors:  H O Kim; X D Ji; S M Siddiqi; M E Olah; G L Stiles; K A Jacobson
Journal:  J Med Chem       Date:  1994-10-14       Impact factor: 7.446

View more
  12 in total

1.  [3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors.

Authors:  X Ji; Y C Kim; D G Ahern; J Linden; K A Jacobson
Journal:  Biochem Pharmacol       Date:  2001-03-15       Impact factor: 5.858

2.  Cell-specific differential modulation of human trabecular meshwork cells by selective adenosine receptor agonists.

Authors:  Mike O Karl; Kim Peterson-Yantorno; Mortimer M Civan
Journal:  Exp Eye Res       Date:  2006-10-30       Impact factor: 3.467

3.  The role of mechanical forces and adenosine in the regulation of intestinal enterochromaffin cell serotonin secretion.

Authors:  A Chin; B Svejda; B I Gustafsson; A B Granlund; A K Sandvik; A Timberlake; B Sumpio; R Pfragner; I M Modlin; M Kidd
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-28       Impact factor: 4.052

4.  A3 Adenosine Receptors: Protective vs. Damaging Effects Identified Using Novel Agonists and Antagonists.

Authors:  Kenneth A Jacobson; Stefano Moro; Yong-Chul Kim; An-Hu Li
Journal:  Drug Dev Res       Date:  1999-03-01       Impact factor: 4.360

5.  Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist.

Authors:  Laura H Heitman; Thea Mulder-Krieger; Ronald F Spanjersberg; Jacobien K von Frijtag Drabbe Künzel; Alessandro Dalpiaz; Adriaan P IJzerman
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

6.  Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A2B adenosine receptor antagonists.

Authors:  Anna Vlachodimou; Henk de Vries; Milena Pasoli; Miranda Goudswaard; Soon-Ai Kim; Yong-Chul Kim; Mirko Scortichini; Melissa Marshall; Joel Linden; Laura H Heitman; Kenneth A Jacobson; Adriaan P IJzerman
Journal:  Biochem Pharmacol       Date:  2022-04-06       Impact factor: 6.100

7.  Recent improvements in the development of A(2B) adenosine receptor agonists.

Authors:  Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Francesca Fruttarolo; Romeo Romagnoli; Delia Preti
Journal:  Purinergic Signal       Date:  2009-01-31       Impact factor: 3.765

8.  2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors.

Authors:  Zhan-Guo Gao; Liaman K Mamedova; Peiran Chen; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2004-11-15       Impact factor: 5.858

9.  AMP579 is revealed to be a potent A2b-adenosine receptor agonist in human 293 cells and rabbit hearts.

Authors:  Yanping Liu; Xiulan Yang; Xi-Ming Yang; Sheree Walker; Karina Förster; Michael V Cohen; Thomas Krieg; James M Downey
Journal:  Basic Res Cardiol       Date:  2010-01       Impact factor: 17.165

10.  Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.

Authors:  Y C Kim; X Ji; N Melman; J Linden; K A Jacobson
Journal:  J Med Chem       Date:  2000-03-23       Impact factor: 8.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.